High energy shock waves (HESW) enhance paclitaxel cytotoxicity in MCF-7 cells

Breast Cancer Research and Treatment

Volumn 81, Issue 1, 2003, Pages 11-19

  Frairia, Roberto ^a   Catalano, Maria G ^b   Fortunati, Nicoletta ^b   Fazzari, Annamaria ^a   Raineri, Mariangela ^a   Berta, Laura ^a  

^a UNIVERSITY OF TURIN   (Italy)

^b MOLINETTE HOSPITAL   (Italy)

Author keywords

Apoptosis; Breast cancer; High energy shock waves (HESW); MCF 7 cells; Paclitaxel; Shock wave treatment

Indexed keywords

PACLITAXEL;

APOPTOSIS; ARTICLE; BREAST CARCINOMA; CANCER CELL; CELL CULTURE; CELL GROWTH; CELL PROLIFERATION; CELL STRAIN MCF 7; CELL VIABILITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOTOXICITY; DENSITY; ENERGY; EXPOSURE; GROWTH INHIBITION; HUMAN; HUMAN CELL; PIEZOELECTRICITY; PRIORITY JOURNAL; SHOCK WAVE; STATISTICAL SIGNIFICANCE;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; APOPTOSIS; BREAST NEOPLASMS; CELL LINE, TUMOR; CELL SURVIVAL; COMBINED MODALITY THERAPY; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HIGH-ENERGY SHOCK WAVES; HUMANS; PACLITAXEL; TREATMENT OUTCOME;

EID: 0043238906     PISSN: 01676806     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1025477421467     Document Type: Article

References (51)

1. Russo P, Stephenson RA, Mies C, Huryk R, Heston WDW, Melamed MR, Fair WR: High energy shock waves suppress tumor growth in vitro and in vivo. J Urol 135: 626-628, 1986
2. Randazzo RF, Chaussy GC, Fuchs GJ, Bhuta SM, Lovrekovich H, de Kemion JB: The in vitro and in vivo effects of extracorporeal shock waves on malignant cells. Urol Res 16: 419-426, 1988
3. Gambihler S, Delius M, Brendel W: Biological effects of shock waves: cell disruption, viability, and proliferation of L1210 cells exposed to shock waves in vitro. Ultrasound Med Biol 16: 587-593, 1990
4. Gamarra F, Spelsberg F, Dellian M, Goetz AE: Complete local tumor remission after therapy with extra-corporeally applied high-energy shock waves (HESW). Int J Cancer 55: 153-156, 1993
5. Huber PE, Debus J: Tumor cytotoxicity in vivo and radical formation in vitro depend on the shock wave-induced cavitation dose. Radiat Res 156: 301-309, 2001
6. Oosterhof GON, Smits GAHJ, de Ruyter JE, van Moorselar RJA, Schalken JA, Debruyne FMJ: The in vitro effect of electromagnetically generated shock waves (Lithostar) on the Dunning R3327 PAT-2 rat prostatic cancer cell-line. A potentiating effect on the in vitro cytotoxicity of vinblastin. Urol Res 17: 13-19, 1989
7. Clayman RV, Long S, Marcus M: High energy shock waves: in vitro effects. Am J Kidney Dis 17: 436-444, 1991
8. Jones BJ, McHale AP, Butler MR: Effect of high-energy shock wave frequency on viability of malignant cell lines in vitro. Eur Urol 22: 70-73, 1992
9. Yao CZ, Ishizuka J, Bold RJ, Townsend Jr CM, Thompson JC: Cytocidal effect of high energy shock wave on tumor cells enhanced with larger dose and multiple exposures. Surg Oncol 3: 229-235, 1994
10. Roessler W, Rothgangel B, Hofstaedter F, Wieland WF: Treatment of human renal cell carcinoma with high-energy shock waves: a new in vivo/in vitro model. Urol Intern 55: 1-5, 1995
11. Wilmer A, Gambihler S, Delius M, Brendel W: In vitro cytotoxicity activity of lithotripter shock waves combined with adriamycin or with cisplatin on L1210 mouse leukemia cells. J Cancer Res Clin Oncol 115: 229-234, 1989
12. Gambihler S, Delius M: In vitro effects of lithotripter shock waves and cytotoxic drugs. Br J Cancer 66: 69-73, 1992
13. Wörle K, Steinbach P, Hofstädter F: The combined effects of high-energy shock waves and cytostatic drugs or cytokines on human bladder cancer cells. Br J Cancer 69: 58-65, 1994
14. Prat F, Sibille A, Luccioni C, Pansu D, Chapelon JY, Beaumatin J, Ponchon T, Cathignol D: Increased chemocytotoxicity to colon cancer cells by shock wave-induced cavitation. Gastroenterology 106: 937-944, 1994
15. Kambe M, Ioritani N, Kanamaru R: Enhancement of chemotherapeutic effects with focused shock waves: extracorporeal shock wave chemotherapy (ESWC). Hum Cell 10: 87-94, 1997
16. Kato M, Ioritani N, Suzuki T, Kambe M, Inaba Y, Watanabe R, Sasano H, Orikasa S: Mechanism of anti-tumor effect of combination of bleomycin and shock waves. Jpn J Cancer Res 91: 1065-1072, 2000
17. Ferlazzo G, Scisca C, Iemmo R, Quartarone G, Cicciarello R, Gagliardi ME, Mesiti M: Cytotoxic effects of high energy shock waves on cancer cells linked to metallic beads vehicled by monoclonal antibodies. J Urol 157: 366-370, 1997
18. Perez EA: Paclitaxel in breast cancer. Oncologist 3: 373-389, 1998
19. Wang LG, Liu XM, Kreis W, Budman DR: The effect of antimicrotubule agents on signal transduction pathways of apoptosis: a review. Cancer Chemother Pharmacol 44: 355-361, 1999
20. Gambihler S, Delius M, Ellwart JW: Permeabilization of the plasma membrane of L1210 mouse leukemia cells using lithotripter shock waves. J Membr Biol 141: 267-275, 1994
21. Delius M, Adams G: Shock wave permeabilization with ribosome inactivating proteins: a new approach to tumor therapy. Cancer Res 59: 5227-5232, 1999
22. Kodama T, Hamblin MR, Doukas AG: Cytoplasmic molecular delivery with shock waves: importance of impulse. Biophys J 79: 1821-1832, 2000
23. Kodama T, Doukas AG, Hamblin MR: Shock wave-mediated molecular delivery into cells. Biochim Biophys Acta 1542: 186-194, 2002
24. Cohen JJ: Apoptosis. Immunol Today 14: 126-130, 1993
25. Steller H: Mechanism and genes of cellular suicide. Science (Washington DC) 267: 1445-1449, 1995
26. Quintans J, Kilkus J, McShan CL, Gottschalk AR, Dawson G: Ceramide mediates the apoptotic response of WEHI 231 cells to anti-immunoglobulin, corticosteroids and irradiation. Biochem Biophys Res Commun 202: 710-714, 1994
27. Ashus H, Rozenszajn LA, Blass M, Barda-Saad M, Azimov D, Radnay J, Zipori D, Rosenschein U: Apoptosis induction of human myeloid leukemia cells by ultrasound exposure. Cancer Res 60: 1014-1020, 2000
28. Feril Jr LB, Kondo T, Zhao QI, Ogawa R: Enhancement of hypertermia-induced apoptosis by non-thermal effects of ultrasound. Cancer Lett 178: 63-70, 2002
29. Lagneaux L, Cordemans de Meulenaer E, Delforge A, Dejeneffe M, Massy M, Moerman C, Hannecart B, Canivet Y, Lepeltier MF, Bron D: Ultrasonic low-energy treatment: a novel approach to induce apoptosis in human leukemic cells. Exp Hematol 30: 1293-1301, 2002
30. Folberth W, Kohler G, Rohwedder A, Matura E: Pressure distribution and energy flow in the focal region of two different electromagnetic shock wave sources. J Stone Dis 4: 1-7, 1992
31. Ogden JA, Alvarez RG, Levitt R, Marlow M: Shock wave therapy (Orthotripsy®) in musculoskeletal disorders. Clin Orthop 387: 22-40, 2001
32. Wess O, Ueberle F, Dürßen RN, Hilcken D, Krauß W, Reuner T, Schultheiß R, Staudenraus I, Rattner M, Haaks W, Granz B: Working group technical developments - consensus report. In: Chaussy C, Eisenberger F, Jocham D, Wilbert D (eds) High Energy Shock Waves in Medicine. Clinical Application in Urology, Gastroenterology and Orthopedics. Georg Thieme Verlag, Stuttgart, New York, 1997, pp 59-71
33. Mosmann T: Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 65: 55-63, 1983
34. Delius M, Denk R, Berding C, Liebich HG, Jordan M, Brendel W: Biological effects of shock waves: cavitation by shock waves in piglet liver. Ultrasound Med Biol 16: 467-472, 1990
35. Miller DL, Thomas RM: The role of cavitation in the induction of cellular DNA damage by ultrasound and lithotripter shock waves in vitro. Ultrasound Med Biol 22: 681-687, 1996
36. Paridaens R, Biganzoli L, Bruning P, Klijn JG, Gamucci T, Houston S, Coleman R, Schachter J, Van Vreckem A, Sylvester R, Awada A, Wildiers J, Piccart M: Paclitaxel versus doxorubicin as first-line single-agent chemotherapy for metastatic breast cancer: a European Organization for Research and Treatment of Cancer Randomized Study with cross-over. J Clin Oncol 18: 724-733, 2000
37. Jordan MA, Toso RJ, Thrower D, Wilson L: Mechanism of mitotic block and inhibition of cell proliferation by taxol at low concentrations. Proc Natl Acad Sci USA 90: 9552-9556, 1993
38. Bacus SS, Gudkov AV, Lowe M, Lyass L, Yung Y, Komarov AP, Keyomarsi K, Yarden Y, Seger R: Taxol-induced apoptosis depend on MAP kinase pathways (ERK and p38) and is independent of p53. Oncogene 20: 147-155, 2001
39. Charles AG, Han T-Y, Liu YY, Hansen N, Giuliano AE, Cabot MC: Taxol-induced ceramide generation and apoptosis in human breast cancer cells. Cancer Chemother Pharmacol 47: 444-450, 2001
40. Lee S, Yang W, Lan K-H, Sellappan S, Klos K, Hortobagyi G, Hung M-C, Yu D: Enhanced sensitization to taxol-induced apoptosis by herceptin pretreatment in ErbB2-overexpressing breast cancer cells. Cancer Res 62: 5703-5710, 2002
41. Beherens P, Brinkmann U, Wellman A: CSEIL/CAS: its role in proliferation and apoptosis. Apoptosis 8: 39-44, 2003
42. Oldham EA, Li C, Ke S, Wallace S, Huang P: Comparison of action of paclitaxel and poly(L-glutamic acid)-paclitaxel conjugate in human breast cancer cells. Int J Oncol 16: 125-132, 2000
43. Blajeski AL, Kottke TJ, Kaufmann SH: A multistep model for paclitaxel-induced apoptosis in human breast cancer cell lines. Exp Cell Res 270: 277-288, 2001
44. Au JL-S, Li D, Gan Y, Gao X, Johnson AL, Johnston J, Millenhaugh NJ, Jang SH, Kuh H-J, Chen C-T, Wienjes MG: Pharmacodynamics of immediate and delayed effects of paclitaxel: role of slow apoptosis and intracellular drug retention. Cancer Res 58: 2141-2148, 1998
45. Lindahl T, Satoh MS, Poirier GG, Klungland A: Post-translational modification of poly(ADP-ribose) polymerase induced by DNA strand breaks. Trends Biochem Sci 20: 405-411, 1995
46. Janicke RU, Sprengart ML, Wati MR, Porter AG: Caspase-3 is required for DNA fragmentation and morphological changes associated with apoptosis. J Biol Chem 273: 9357-9360, 1998
47. Rossini GP, Sgarbi N, Malaguti C: The toxic responses induced by okadaic acid involve processing of multiple caspase isoforms. Toxicon 39: 763-770, 2001
48. Liu XM, Wang LG, Kreis W, Budman DR, Adams LM: Differential effect of vinorelbine versus paclitaxel on ERK2 kinase activity during apoptosis in MCF-7 cells. Br J Cancer 85: 1403-1411, 2001
49. Lauer U, Burgelt E, Squire Z, Messmer K, Hofschneider PH, Gregor M, Delius M: Shock wave permeabilization as a new gene transfer method. Gene Ther 4: 710-715, 1997
50. Tschoep K, Hartmann G, Jox R, Thompson S, Eigler A, Krug A, Erhardt S, Adams G, Endres S, Delius M: Shock waves: a novel method for cytoplasmic delivery of antisense nucleotides. J Mol Med 79: 306-323, 2001
51. Kodama T, Doukas AG, Hamblin MR: Delivery of ribosome-inactivating protein toxin into cancer cells with shock waves. Cancer Lett 189: 69-75, 2003